Company / Revenue
Doximity Revenue History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$570.4M
FY2024
5-year range
$343.5M / $570.4M
FY2020-FY2024
Trend
+20.0%
vs FY2023
Sector context
#115 of 150
Health Care
What the data says
Doximity's revenue of $570M is lower than 77% of companies in the Health Care sector (FY2024). Revenue has increased for 5 consecutive years, from $116M in FY2019 to $570M in FY2024.
Based on SEC 10-K filings.
$570M in FY2024 with a 5-year CAGR of +37.4%.
Improved from $419M to $570M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +18.4%
- 5-Year CAGR
- +37.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 150This company $570.4M Sector average $19.5B
▼
-97.1% below sector average
Key checks
Key Insights
- Doximity's revenue has grown for 5 consecutive years.
- 5-year CAGR of +37.4%, indicating consistent growth.
- In FY2024, revenue increased 20.0% year-over-year.
- Ranks #115 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $570.4M | +20.0% |
| FY2023 | $475.4M | +13.5% |
| FY2022 | $419.1M | +22.0% |
| FY2021 | $343.5M | +66.0% |
| FY2020 | $206.9M | +77.8% |
| FY2019 | $116.4M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026